Cancer Screening Schedule After a Previous Cancer

After cancer treatment, you are being watched for two separate things, and conflating them is the single most common cause of a missed test.

Surveillance looks for the cancer you already had. It is organized around your original tumor: scans of that region, tumor markers if they applied, scopes of that organ, physical exams of that area. Its schedule is set by your oncology team and is usually most intense in the first two to five years.

Screening looks for a different cancer, one you have never had, in someone without symptoms. Mammography, colonoscopy, cervical testing, lung CT. Its schedule is set by age and risk factors and runs for decades.

A CT of the chest after lung cancer treatment tells you nothing about your colon. A CEA level after colorectal cancer tells you nothing about your breasts. Being under close oncology follow-up can create a powerful and mistaken sense that everything is being checked.

Nearly one in five cancers diagnosed in the United States today occurs in someone with a previous cancer diagnosis. The survivor population has grown from about 3.5 million in the 1970s to more than 17 million, and second primary cancers are now a leading cause of illness and death in that group.

The elevated risk comes from three overlapping sources.

Shared risk factors. Whatever contributed to the first cancer often has not gone away. Tobacco raises risk across the lung, head and neck, esophagus, bladder, kidney, pancreas, and colon simultaneously.

Treatment effects. Radiotherapy and certain chemotherapy agents, particularly alkylating agents and topoisomerase inhibitors, are established causes of later cancers. The risk is generally small per person and appears years to decades afterward, and it was accepted deliberately at the time in exchange for curing the cancer in front of you.

Inherited susceptibility. A BRCA1, BRCA2, Lynch syndrome, or Li-Fraumeni variant raises risk across several organs at once. If genetic testing was never done, or was done years ago with a narrow panel, it may be worth revisiting.

Most survivors follow ordinary age-based screening, fully rather than partially. Some specific treatment histories add requirements:

• Chest radiation before age 30, common in Hodgkin lymphoma survivors, leads to annual breast MRI plus mammography beginning around age 25 to 30 or roughly 8 years after radiation, well ahead of the usual starting age.
• Colorectal cancer treated surgically carries its own surveillance colonoscopy schedule, typically starting about a year after resection, which is separate from ordinary screening intervals.
• HPV-related cancers and head and neck cancers bring elevated risk of additional cancers in the same tissue field.
• Pelvic radiation raises later risk in nearby organs, which can affect how colorectal and bladder symptoms are approached.
• Stem cell transplant brings a distinct long-term follow-up schedule.

And screening you no longer need should also be retired. If a hysterectomy or a mastectomy removed the organ in question, that test may no longer apply.

This is the practical heart of it. Oncology often assumes primary care is handling routine screening. Primary care often assumes that someone under active cancer follow-up is being comprehensively watched. Neither office is being careless; each is reasoning from a partial view.

Ask directly, in both offices: which tests are you tracking for me, and which are you not. Any test that neither claims will not happen.

A survivorship care plan is a document, usually a few pages, that records what cancer you had, what treatment you received including radiation fields and cumulative drug doses, what long-term risks that creates, and a schedule of follow-up naming the responsible clinician for each item.

It matters for a mundane reason: you will change insurers, move, and change doctors, and a clinician meeting you in fifteen years will have no way to know you received anthracyclines or mantle-field radiation unless you can hand them the record. Keep a copy yourself. Give a copy to every new clinician.

And keep one habit from treatment intact: new, persistent, unexplained symptoms get reported and evaluated, whether or not a scan was recently clear.

• American Cancer Society: Second cancers in adults
• NCI: Follow-up medical care after cancer treatment
• American Cancer Society guidelines for the early detection of cancer
• NCI: The genetics of cancer